Skip to content
OpenCapital
Get started

Arbutus Biopharma Corporation ABUS EPS (Diluted)

EPS (Diluted) at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
-$0.93-134%
Gilead Sciences logo
Gilead SciencesGILD
$1.61+54.8%
ALN
Alnylam PharmaceuticalsALNY
$1.51+1,179%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$1.84-43.8%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$0.98+21.6%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
-$0.85+3.4%

Other financials

Income statement

See full
Revenue$179.1M+10,055%
Operating income$168.9M+757%
Net income$169.7M+792%

Balance sheet

See full
Cash & equivalents$23.7M-36.1%
Total debt$631.0K-46.9%
Total equity$260.2M+229%
Total assets$277.2M+137%

Cash flow

See full
Operating cash flow-$8.1M+39.4%
CapEx--100%
Free cash flow-$4.7M+55.0%

Valuation

See full
Market cap$881.02M+34.1%
Enterprise value$857.94M+38.1%
P/E5.5×—
P/S4.6×-98.0×

Profitability

See full
Operating margin81.7%+42.1pp
Net margin84%+43.4pp
FCF margin-281.5%-119pp

Returns & leverage

See full
Return on equity94.7%+65.1pp
Debt / equity0×0.0×
Current ratio54.3×+48.3×

Where this comes from

Reported directly by Arbutus Biopharma Corporation in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arbutus Biopharma Corporation's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arbutus Biopharma Corporation's EPS (diluted)?
Arbutus Biopharma Corporation (ABUS) reported EPS (diluted) of $0.87 in Q1 2026.
How has Arbutus Biopharma Corporation's EPS (diluted) changed year-over-year?
Arbutus Biopharma Corporation's EPS (diluted) increased by 769.2% year-over-year, from -$0.13 to $0.87.
What is the long-term trend for Arbutus Biopharma Corporation's EPS (diluted)?
Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's EPS (diluted) has grown at a -32.7% compound annual growth rate (CAGR), from -$0.83 to -$0.17.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.